Logo image of CNMD

CONMED CORP (CNMD) Stock Price, Forecast & Analysis

USA - New York Stock Exchange - NYSE:CNMD - US2074101013 - Common Stock

40.57 USD
+0.5 (+1.25%)
Last: 12/8/2025, 8:04:00 PM
40.57 USD
0 (0%)
After Hours: 12/8/2025, 8:04:00 PM

CNMD Key Statistics, Chart & Performance

Key Statistics
Market Cap1.26B
Revenue(TTM)1.35B
Net Income(TTM)64.32M
Shares30.97M
Float30.79M
52 Week High74.7
52 Week Low38.95
Yearly Dividend0.8
Dividend Yield1.81%
EPS(TTM)4.52
PE8.98
Fwd PE8.31
Earnings (Next)02-03 2026-02-03/amc
IPO1987-07-23
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


CNMD short term performance overview.The bars show the price performance of CNMD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20

CNMD long term performance overview.The bars show the price performance of CNMD in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of CNMD is 40.57 USD. In the past month the price decreased by -7.73%. In the past year, price decreased by -44.08%.

CONMED CORP / CNMD Daily stock chart

CNMD Latest News, Press Relases and Analysis

CNMD Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 24.47 212.30B
ISRG INTUITIVE SURGICAL INC 65.84 200.96B
BSX BOSTON SCIENTIFIC CORP 31.81 139.11B
SYK STRYKER CORP 26.85 135.22B
IDXX IDEXX LABORATORIES INC 56.04 56.43B
BDX BECTON DICKINSON AND CO 13.14 54.09B
EW EDWARDS LIFESCIENCES CORP 32.81 48.93B
GEHC GE HEALTHCARE TECHNOLOGY 18.1 37.85B
RMD RESMED INC 25.26 36.50B
DXCM DEXCOM INC 35.28 25.59B
PODD INSULET CORP 64.81 20.84B
ZBH ZIMMER BIOMET HOLDINGS INC 11.46 18.38B

About CNMD

Company Profile

CNMD logo image CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. The company is headquartered in Largo, Florida and currently employs 3,900 full-time employees. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.

Company Info

CONMED CORP

11311 Concept Boulevard

Largo FLORIDA 33773 US

CEO: Curt R. Hartman

Employees: 3900

CNMD Company Website

CNMD Investor Relations

Phone: 17272142974

CONMED CORP / CNMD FAQ

What does CONMED CORP do?

CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. The company is headquartered in Largo, Florida and currently employs 3,900 full-time employees. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.


What is the stock price of CONMED CORP today?

The current stock price of CNMD is 40.57 USD. The price increased by 1.25% in the last trading session.


Does CONMED CORP pay dividends?

CONMED CORP (CNMD) has a dividend yield of 1.81%. The yearly dividend amount is currently 0.8.


How is the ChartMill rating for CONMED CORP?

CNMD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the Price/Earnings (PE) ratio of CONMED CORP (CNMD)?

The PE ratio for CONMED CORP (CNMD) is 8.98. This is based on the reported non-GAAP earnings per share of 4.52 and the current share price of 40.57 USD.


Can you provide the upcoming dividend date for CONMED CORP?

The next ex-dividend date for CONMED CORP (CNMD) is September 15, 2025.


When does CONMED CORP (CNMD) report earnings?

CONMED CORP (CNMD) will report earnings on 2026-02-03, after the market close.


CNMD Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

CNMD Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to CNMD. While CNMD has a great profitability rating, there are quite some concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CNMD Financial Highlights

Over the last trailing twelve months CNMD reported a non-GAAP Earnings per Share(EPS) of 4.52. The EPS increased by 16.49% compared to the year before.


Industry RankSector Rank
PM (TTM) 4.77%
ROA 2.77%
ROE 6.38%
Debt/Equity 0.85
Chartmill High Growth Momentum
EPS Q2Q%2.86%
Sales Q2Q%6.7%
EPS 1Y (TTM)16.49%
Revenue 1Y (TTM)4.61%

CNMD Forecast & Estimates

12 analysts have analysed CNMD and the average price target is 55.08 USD. This implies a price increase of 35.77% is expected in the next year compared to the current price of 40.57.

For the next year, analysts expect an EPS growth of 10.38% and a revenue growth 5.12% for CNMD


Analysts
Analysts73.33
Price Target55.08 (35.77%)
EPS Next Y10.38%
Revenue Next Year5.12%

CNMD Ownership

Ownership
Inst Owners114.32%
Ins Owners0.29%
Short Float %7.31%
Short Ratio4.97